MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/liv.70487

Медицинская библиотека · Liver international : official journal of the International Association for the Study of the Liver · 2026

Characteristics and Clinical Outcomes in Patients With Cirrhosis due to MASLD in Sweden.

Shang Ying, Widman Linnea, Zhang Xiao, Fernandes Gail, Melaragno Matthew G, Engel Samuel S, Vessby Johan, Ekstedt Mattias, Hagström Hannes

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND AND AIMS: There is limited real-world data on the prognosis of patients with cirrhosis due to metabolic dysfunction-associated steatotic liver disease (MASLD). We sought to describe the characteristics and assess the clinical course of MASLD-cirrhosis.

METHODS

A Swedish register-based cohort including 2318 patients with compensated and 1339 with decompensated cirrhosis due to MASLD from 2001 to 2020 was analysed. Incidence rates of severe clinical events including decompensated cirrhosis, liver transplantation or overall mortality were estimated. We further compared the results using a clinical cohort of 293 patients with MASLD- cirrhosis from three University Hospitals.

RESULTS

Overall, 55.7% patients with compensated cirrhosis (median age 70, 43.6% female, 88.7% type 2 diabetes [T2D]) developed severe clinical events during a median follow-up of 1.1 years. The incidence rate was 78.5/1000 person-year (PY), 6.8/1000 PY and 182.0/1000 PY for decompensation, liver transplantation and death, respectively. Among 1399 patients with decompensated cirrhosis (median age 72, 41.1% female, 86% T2D), ascites (74.6%) was the most frequent initial events. 59.7% experienced death or transplantation with a median follow-up of 0.58 years. The incidence rate was 14.0/1000 PY for liver transplantation and 353.2/1000 PY for overall death. Estimates were similar in the clinical cohort but lower overall mortality were observed (IR = 63.1/1000 PY in compensated cirrhosis and 188.2/1000 PY in decompensated events).

CONCLUSIONS

This study describes the clinical characteristics and the natural history of patients with MASLD-cirrhosis by compensation status in Sweden, providing estimates for important outcomes that may be useful for patient prognostication and clinical trial design.

Для цитирования: Shang Ying, Widman Linnea, Zhang Xiao, Fernandes Gail, Melaragno Matthew G, Engel Samuel S, Vessby Johan, Ekstedt Mattias, Hagström Hannes. Characteristics and Clinical Outcomes in Patients With Cirrhosis due to MASLD in Sweden.. Liver international : official journal of the International Association for the Study of the Liver. 2026. DOI: 10.1111/liv.70487.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.